A holistic approach to targeting disease with polymeric nanoparticles
Open accessThe DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Abstract
The primary goal of nanomedicine is to improve clinical outcomes. To this end, targeted nanoparticles are engineered to reduce non-productive distribution while improving diagnostic and therapeutic efficacy. Paradoxically, as this field has matured, the notion of targeting has been minimized to the concept of increasing the affinity of a nanoparticle for its target. This Opinion article outlines a holistic view of nanoparticle targeting, in which the route of administration, molecular characteristics and temporal control of the nanoparticles are potential design variables that must be considered simultaneously. This comprehensive vision for nanoparticle targeting will facilitate the integration of nanomedicines into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Encapsulation of hepcidin into biocompatible nanocarriers suitable for controlled release of therapeutics (Cheng et al., 2015) could theoretically address this issue.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Cheng et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Theranostics: Combining Imaging and Therapy
Kelkar, S. S., & Reineke, T. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200151q · Cited by 1,385
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., & Tsourkas, A. (2012) · Science · doi:10.1126/science.1226338 · Cited by 1,322
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
RNAi therapeutics: a potential new class of pharmaceutical drugs
Bumcrot, D., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,085
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Cheng, C. J., Bahal, R., Babar, I. A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2015) · Nature · doi:10.1038/nature13905 · Cited by 823
Self-citation(1990) · PubMed · Cited by 757
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Bertrand, N., & Leroux, J.-C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.098 · Cited by 707
Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium
Kolhar, P., Anselmo, A. C., Gupta, V., Pant, K., Prabhakarpandian, B., Ruoslahti, E., & Mitragotri, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308345110 · Cited by 646
Breaking down the barriers: siRNA delivery and endosome escape
Dominska, M., & Dykxhoorn, D. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.066399 · Cited by 630
Perry, J. L., Reuter, K. G., Kai, M. P., Herlihy, K. P., Jones, S. W., Luft, J. C., Napier, M., Bear, J. E., & DeSimone, J. M. (2012) · Nano Letters · doi:10.1021/nl302638g · Cited by 606
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
Dahlman, J. E., Barnes, C., Khan, O. F., Thiriot, A., Jhunjunwala, S., Shaw, T. E., Xing, Y., Sager, H. B., Sahay, G., Speciner, L., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.84 · Cited by 592
Hühn, D., Kantner, K., Geidel, C., Brandholt, S., De Cock, I., Soenen, S. J. H., Rivera_Gil, P., Montenegro, J.-M., Braeckmans, K., Müllen, K., et al. (2013) · ACS Nano · doi:10.1021/nn3059295 · Cited by 580
Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S.-B., Rha, S. Y., Lee, M. Y., & Ro, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9591-y · Cited by 541
Nanoparticles for Brain Drug Delivery
Masserini, M. (2013) · ISRN Biochemistry · doi:10.1155/2013/238428 · Cited by 489
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Shi, J., Xiao, Z., Kamaly, N., & Farokhzad, O. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar200054n · Cited by 476
A New Approach to the Oral Administration of Insulin and Other Peptide Drugs
Saffran, M., Kumar, G. S., Savariar, C., Burnham, J. C., Williams, F., & Neckers, D. C. (1986) · Science · doi:10.1126/science.3526553 · Cited by 469
Yun, Y., Cho, Y. W., & Park, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 444
Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., & Mark Saltzman, W. (2009) · Nature Materials · doi:10.1038/nmat2444 · Cited by 438
Self-citationTransepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 405
Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage
Rothenfluh, D. A., Bermudez, H., O’Neil, C. P., & Hubbell, J. A. (2008) · Nature Materials · doi:10.1038/nmat2116 · Cited by 388
Penetration of nanoparticles and nanomaterials in the skin: Fiction or reality?
Baroli, B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21817 · Cited by 372
Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
Ensign, L. M., Tang, B. C., Wang, Y.-Y., Tse, T. A., Hoen, T., Cone, R., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003453 · Cited by 368
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo, K. F., & Chang, E. H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347
Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines
Kunjachan, S., Pola, R., Gremse, F., Theek, B., Ehling, J., Moeckel, D., Hermanns-Sachweh, B., Pechar, M., Ulbrich, K., Hennink, W. E., et al. (2014) · Nano Letters · doi:10.1021/nl404391r · Cited by 317
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions?
Rivolta, I., Panariti, & Miserocchi (2012) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s25515 · Cited by 308
Jin, Y., Song, Y., Zhu, X., Zhou, D., Chen, C., Zhang, Z., & Huang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.075 · Cited by 301
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
Allard, E., Passirani, C., & Benoit, J.-P. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.003 · Cited by 294
Nanopreparations for organelle-specific delivery in cancer
Biswas, S., & Torchilin, V. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.004 · Cited by 292
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Pharmacokinetics of the Carmustine Implant
Fleming, A. B., & Saltzman, W. M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241060-00002 · Cited by 287
Self-citationIntravesical drug delivery: Challenges, current status, opportunities and novel strategies
GuhaSarkar, S., & Banerjee, R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.031 · Cited by 285
Polymer multilayer tattooing for enhanced DNA vaccination
DeMuth, P. C., Min, Y., Huang, B., Kramer, J. A., Miller, A. D., Barouch, D. H., Hammond, P. T., & Irvine, D. J. (2013) · Nature Materials · doi:10.1038/nmat3550 · Cited by 277
Gold, Poly(β-amino ester) Nanoparticles for Small Interfering RNA Delivery
Lee, J.-S., Green, J. J., Love, K. T., Sunshine, J., Langer, R., & Anderson, D. G. (2009) · Nano Letters · doi:10.1021/nl9009793 · Cited by 276
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Zhou, J., Patel, T. R., Sirianni, R. W., Strohbehn, G., Zheng, M.-Q., Duong, N., Schafbauer, T., Huttner, A. J., Huang, Y., Carson, R. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304504110 · Cited by 271
Self-citationCu, Y., & Saltzman, W. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8001254 · Cited by 267
Self-citationWerner, M. E., Cummings, N. D., Sethi, M., Wang, E. C., Sukumar, R., Moore, D. T., & Wang, A. Z. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.02.009 · Cited by 267
Nanoscale technology of mucoadhesive interactions
Peppas, N. A., & Huang, Y. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.03.001 · Cited by 264
Biodegradable Nanoparticles Composed Entirely of Safe Materials that Rapidly Penetrate Human Mucus
Yang, M., Lai, S. K., Wang, Y., Zhong, W., Happe, C., Zhang, M., Fu, J., & Hanes, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006849 · Cited by 260
An overview of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00144-8 · Cited by 254
de Titta, A., Ballester, M., Julier, Z., Nembrini, C., Jeanbart, L., van der Vlies, A. J., Swartz, M. A., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313152110 · Cited by 254
Enhancement of Topical Delivery from Biodegradable Nanoparticles
Alvarez-Rom#x00E1;n, R., Naik, A., Kalia, Y. N., Guy, R. H., & Fessi, H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045235.86197.ef · Cited by 248
Rupp, R. E., Rosenthal, S. L., & Stanberry, L. R. (2007) · PubMed · Cited by 235
Weiss, G. J., Chao, J., Neidhart, J. D., Ramanathan, R. K., Bassett, D., Neidhart, J. A., Choi, C. H. J., Chow, W., Chung, V., Forman, S. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9921-8 · Cited by 230
Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
Crooke, S. T., Graham, M. J., Zuckerman, J. E., Brooks, D., Conklin, B. S., Cummins, L. L., Greig, M. J., Guinosso, C. J., Kornbrust, D., Manoharan, M., et al. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12951-0 · Cited by 227
Controlled release for local delivery of drugs: barriers and models
Weiser, J. R., & Saltzman, W. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.048 · Cited by 225
Self-citationBiodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
Kohane, D. S., Tse, J. Y., Yeo, Y., Padera, R., Shubina, M., & Langer, R. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30654 · Cited by 217
Desai, P. R., Marepally, S., Patel, A. R., Voshavar, C., Chaudhuri, A., & Singh, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.021 · Cited by 188
Suk, J. S., Lai, S. K., Boylan, N. J., Dawson, M. R., Boyle, M. P., & Hanes, J. (2011) · Nanomedicine · doi:10.2217/nnm.10.123 · Cited by 185
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
Roa, W. H., Azarmi, S., Al-Hallak, M. H. D. K., Finlay, W. H., Magliocco, A. M., & Löbenberg, R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.035 · Cited by 181
Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors
Zhou, J., Patel, T. R., Fu, M., Bertram, J. P., & Saltzman, W. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.061 · Cited by 176
Self-citationNanotherapy for posterior eye diseases
Kaur, I. P., & Kakkar, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.031 · Cited by 175
Loverde, S. M., Klein, M. L., & Discher, D. E. (2012) · Advanced Materials · doi:10.1002/adma.201103192 · Cited by 162
Targeted nanoparticles with novel non-peptidic ligands for oral delivery
Rieux, A. D., Pourcelle, V., Cani, P. D., Marchand‐Brynaert, J., & Préat, V. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.002 · Cited by 159
Papa, S., Rossi, F., Ferrari, R., Mariani, A., De Paola, M., Caron, I., Fiordaliso, F., Bisighini, C., Sammali, E., Colombo, C., et al. (2013) · ACS Nano · doi:10.1021/nn4036014 · Cited by 159
Merki, E., Graham, M. J., Mullick, A. E., Miller, E. R., Crooke, R. M., Pitas, R. E., Witztum, J. L., & Tsimikas, S. (2008) · Circulation · doi:10.1161/circulationaha.108.786822 · Cited by 156
Yoo, M. K., Kang, S., Choi, J.-H., Park, I., Na, H. S., Lee, H., Kim, E.-B., Lee, N.-K., Nah, J., Choi, Y.-J., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.059 · Cited by 150
Moghimi, S. M., Hawley, A. E., Christy, N. M., Gray, T., Illum, L., & Davis, S. S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00351-3 · Cited by 150
Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating Curcumin
Cartiera, M. S., Ferreira, E. C., Caputo, C., Egan, M. E., Caplan, M. J., & Saltzman, W. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900138a · Cited by 146
Self-citationKourtis, I. C., Hirosue, S., de Titta, A., Kontos, S., Stegmann, T., Hubbell, J. A., & Swartz, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061646 · Cited by 145
Eliasof, S., Lazarus, D., Peters, C. G., Case, R. I., Cole, R. O., Hwang, J., Schluep, T., Chao, J., Lin, J., Yen, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309566110 · Cited by 144
Deng, Y., Saucier-Sawyer, J. K., Hoimes, C. J., Zhang, J., Seo, Y.-E., Andrejecsk, J. W., & Saltzman, W. M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.038 · Cited by 144
Self-citationSchaffer, D. V., & Lauffenburger, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28004 · Cited by 141
Ulery, B. D., Kumar, D., Ramer‐Tait, A. E., Metzger, D. W., Wannemuehler, M. J., & Narasimhan, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017642 · Cited by 137
Moghimi, S. M. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00099-4 · Cited by 135
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery
Cu, Y., Booth, C. J., & Saltzman, W. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.036 · Cited by 129
Self-citationVij, N., Min, T., Marasigan, R., Belcher, C. N., Mazur, S., Ding, H., Yong, K.-T., & Roy, I. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-22 · Cited by 126
Liu, Y., Feng, L., Liu, T., Zhang, L., Yao, Y., Yu, D., Wang, L., & Zhang, N. (2014) · Nanoscale · doi:10.1039/c3nr05647c · Cited by 126
Cheng, C. J., & Saltzman, W. M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.053 · Cited by 120
Self-citationSawyer, A. J., Saucier-Sawyer, J. K., Booth, C. J., Liu, J., Patel, T., Piepmeier, J. M., & Saltzman, W. M. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-010-0001-3 · Cited by 118
Self-citationNew methods for direct delivery of chemotherapy for treating brain tumors.
Sawyer, A. J., Piepmeier, J. M., & Saltzman, W. M. (2006) · PubMed Central · Cited by 117
Self-citationWang, Y.-Y., Lai, S. K., So, C., Schneider, C., Cone, R., & Hanes, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021547 · Cited by 116
Wang, Y., Wu, Y.-T., Huang, H.-Y., Lin, H.-I., Lo, L., Tzeng, S., & Yang, C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.050 · Cited by 114
Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection
Steinbach, J. M., Weller, C. E., Booth, C. J., & Saltzman, W. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.008 · Cited by 113
Self-citationAnti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel
Zhang, X., Burt, H. M., Mangold, G., Dexter, D., Hoff, D. V., Mayer, L., & Hunter, W. L. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199708000-00008 · Cited by 112
Syntheses of Click PEG−Dexamethasone Conjugates for the Treatment of Rheumatoid Arthritis
Liu, X.-M., Quan, L., Tian, J., Laquer, F. C., Ciborowski, P. S., & Wang, D. (2010) · Biomacromolecules · doi:10.1021/bm100578c · Cited by 110
Neeves, K. B., Sawyer, A. J., Foley, C. P., Saltzman, W. M., & Olbricht, W. L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.050 · Cited by 110
Self-citationYang, M., Yu, T., Wang, Y., Lai, S. K., Zeng, Q., Miao, B., Tang, B. C., Simons, B. W., Ensign, L. M., Liu, G., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300519 · Cited by 106
Drug targeting systems for inflammatory disease: One for all, all for one
Crielaard, B. J., Lammers, T., Schiffelers, R. M., & Storm, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.014 · Cited by 106
Bernal, G. M., LaRiviere, M. J., Mansour, N., Pytel, P., Cahill, K. E., Voce, D. J., Kang, S., Spretz, R., Welp, U., Noriega, S. E., et al. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.07.003 · Cited by 102
Navath, R. S., Menjoge, A. R., Dai, H., Romero, R. J., Kannan, S., & Kannan, R. M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200027z · Cited by 97
Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
das Neves, J., Amiji, M., & Sarmento, B. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.144 · Cited by 97
Widespread suppression of huntingtin with convection-enhanced delivery of siRNA
Stiles, D. K., Zhang, Z., Ge, P., Nelson, B. D., Grondin, R., Ai, Y., Hardy, P., Nelson, P. T., Guzaev, A. P., Butt, M. T., et al. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.020 · Cited by 94
Nanoparticle-Delivered Suicide Gene Therapy Effectively Reduces Ovarian Tumor Burden in Mice
Huang, Y.-H., Zugates, G. T., Peng, W., Holtz, D. O., Dunton, C. J., Green, J. J., Hossain, N., Chernick, M. R., Padera, R. F., Langer, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0061 · Cited by 92
Gugulothu, D. B., Kulkarni, A., Patravale, V. B., & Dandekar, P. P. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23828 · Cited by 91
Barthelmes, J., Perera, G., Hombach, J., Dünnhaupt, S., & Bernkop‐Schnürch, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.06.033 · Cited by 89
Li, H., Tran, V. V., Hu, Y., Saltzman, W. M., Barnstable, C. J., & Tombran‐Tink, J. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.04.014 · Cited by 86
Self-citationStealth particles give mucus the slip
Cu, Y., & Saltzman, W. M. (2009) · Nature Materials · doi:10.1038/nmat2347 · Cited by 82
Self-citationMartin, D. T., Steinbach-Rankins, J. M., Liu, J., Shimizu, S., Kaimakliotis, H. Z., Wheeler, M. A., Hittelman, A. B., Saltzman, W. M., & Weiss, R. M. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0502 · Cited by 82
Self-citationJean, M., Smaoui, F., Lavertu, M., Méthot, S., Bouhdoud, L., Buschmann, M. D., & Merzouki, A. (2009) · Gene Therapy · doi:10.1038/gt.2009.60 · Cited by 76
Luo, Y., Zhai, X., Ma, C., Sun, P., Fu, Z., Liu, W., & Xu, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.005 · Cited by 76
Torosean, S., Flynn, B., Axelsson, J., Gunn, J., Samkoe, K. S., Hasan, T., Doyley, M. M., & Pogue, B. W. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.07.002 · Cited by 73
das Neves, J., Araújo, F., Andrade, F., Amiji, M. M., Bahia, M. F., & Sarmento, B. F. C. C. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1287-x · Cited by 72
Kamei, T., Kitayama, J., Yamaguchi, H., Soma, D., Emoto, S., Konno, T., Ishihara, K., Ishigami, H., Kaisaki, S., & Nagawa, H. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01747.x · Cited by 67
Wang, Y., & Huang, L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2634 · Cited by 67
Moghimi, S. M., & Rajabi‐Siahboomi, A. R. (1996) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(96)00012-0 · Cited by 67
Reddy, L. H., Sharma, R. K., & Murthy, R. S. R. (2004) · Journal of drug targeting · doi:10.1080/10611860400011406 · Cited by 60
Hawley, A. E., Illum, L., & Davis, S. S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01408-1 · Cited by 59
Alqawlaq, S., Sivak, J. M., Huzil, J. T., Ivanova, M. V., Flanagan, J. G., Beazely, M. A., & Földvári, M. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.05.010 · Cited by 52
Nagahama, R., Matoba, T., Nakano, K., Kim‐Mitsuyama, S., Sunagawa, K., & Egashira, K. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.253823 · Cited by 48
Kreuter, J., Nefzger, M., Liehl, E., Czok, R., & Voges, R. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721009 · Cited by 47
Foley, C. P., Nishimura, N., Neeves, K. B., Schaffer, C. B., & Olbricht, W. L. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0440-0 · Cited by 47
Muro, S., & Mane (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34105 · Cited by 43
Rapid Lymph Accumulation of Polystyrene Nanoparticles Following Pulmonary Administration
Mohammad, A. K., Amayreh, L. K., Mazzara, J. M., & Reineke, J. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0884-4 · Cited by 43
Wang, A., Cummings, N. D., Sethi, M., Wang, E., Sukumar, R., Moore, D. T., & Werner, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.e13546 · Cited by 37
Neurosurgical convection-enhanced delivery of treatments for Parkinson’s disease
Lam, M. F., Thomas, M. G., & Lind, C. R. P. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.01.012 · Cited by 34
Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
Gündoğdu, E., & Yurdasiper, A. (2014) · Intern J Endocrinol Metab · doi:10.5812/ijem.8984 · Cited by 29
Blum, J. S., Weller, C. E., Booth, C. J., Babar, I., Liang, X., Slack, F. J., & Saltzman, W. M. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-011-0038-y · Cited by 24
Self-citationIntranasal Delivery of Chitosan–siRNA Nanoparticle Formulation to the Brain
Malhotra, M., Tomaro-Duchesneau, C., Saha, S., & Prakash, S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0363-4_15 · Cited by 22
Pittet, L. A., Altreuter, D. H., Ilyinskii, P. O., Fraser, C., Gao, Y., Baldwin, S., Keegan, M., Johnston, L. P. M., & Kishimoto, T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.188.supp.75.11 · Cited by 17
Biodistribution of 125I-labeled polymeric vaccine carriers after subcutaneous injection
Toita, R., Kanai, Y., Watabe, H., Nakao, K., Yamamoto, S., Hatazawa, J., & Akashi, M. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.021 · Cited by 13
Managing risks of TNF inhibitors: An update for the internist
Hadam, J., Aoun, E. G., Clarke, K., & Wasko, M. C. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.81a.12121 · Cited by 10
Intranasal delivery of nanoparticle-based vaccine increases protection against S. pneumoniae
Mott, B., Thamake, S. I., Vishwanatha, J. K., & Jones, H. P. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1646-x · Cited by 5
Research works printed but not linked: 5
- Bertrand N Leroux JC The journey of a drug-carrier in the body: an anatomo-physiological perspective Journal of Controlled Release: Official Journal of the Controlled Release Society 161 152 163 2012 22001607
- Davis ME Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 1067 U140 2010 20305636 PMC2855406
- Wang YC Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury Biomaterials 29 4546 4553 2008 18774604
- Kaur IP Kakkar S Nanotherapy for posterior eye diseases Journal of Controlled Release: Official Journal of the Controlled Release Society 2014 24862316
- Li H A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres Experimental Eye Research 83 824 833 2006 16822505
Cited by
Drug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
Narayan, R., Nayak, U. Y., Raichur, A. M., & Garg, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030118 · Cited by 942
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
Yong, T., Zhang, X., Bie, N., Zhang, H., Zhang, X., Li, F., Hakeem, A., Hu, J., Gan, L., Santos, H. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11718-4 · Cited by 806
Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 677
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 671
Metadata
- Authors
- Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M.
- Affiliations
- Yale University (US)
- Corresponding author
- Saltzman, W. Mark
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-01-19
- Volume
- 14
- Issue
- 4
- Pages
- 239-247
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC4451203
- OpenAlex
- W2041271505
- Cited by
- 480
- References
- 135
- Citations by year
- 2026: 13 · 2025: 37 · 2024: 31 · 2023: 41 · 2022: 42 · 2021: 37 · 2020: 42 · 2019: 40 · 2018: 46 · 2017: 63 · 2016: 60 · 2015: 27
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-04-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Cancer Institute (R01CA149128, F32CA174247, CA149128)
- National Institute of Allergy and Infectious Diseases (R01AI112443, T32AI089704, AI106992, R56AI106922, AI112443)
- National Institute of Biomedical Imaging and Bioengineering (EB00487, R01EB000487)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- targeted drug delivery, polymeric nanoparticles, nanomedicine, nanoparticle targeting, route of administration, nanoparticle design, clinical translation
- MeSH terms
- Animals, Humans, Polymers, Drug Delivery Systems, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.